Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 February 2022 | Story Lacea Loader | Photo Sonia Small (Kaleidoscope Studios)
Dr Engela van Staden
Dr Engela van Staden, Vice Rector: Academic

The University of the Free State (UFS) has finalised the first part of the Council on Higher Education (CHE) Institutional Audit (IA), submitting its Institutional Self-Evaluation Report (SER) and Portfolio of Evidence (PoE) to the higher education quality assurance body. 

According to Dr Engela van Staden, Vice-Rector: Academic, the second part of the institutional audit will involve the participation of relevant stakeholders in a site visit to the institution. During the visit, scheduled between 9 and 13 May 2022, an external panel of experts will systematically assess the submitted SER and requisite documents by asking inquisitive questions to interviewees who will be participating in this process.  

“The focus will be on the quality of programme offerings with a view to improving student success in all spheres of the student walk – from registration to graduation. To this end, the university’s Integrated Quality Management Framework (IQMF) will be assessed in order to provide evidence that quality assurance is ingrained in the core functions of the UFS, i.e., student success; quality of teaching and research; and engaged scholarship.”

Dr Van Staden says by re-introducing the SER, the university will embark on a stakeholder engagement plan, engaging with staff in faculties, service units, directorates, centres, departments, or schools, to keep them informed and prepared for a productive contribution to the Institutional Audit process. 

- The CHE is an independent statutory body established in terms of the provisions of the Higher Education Act No. 101 of 1997, as amended. It advises the Minister responsible for Higher Education and Training and is the national authority for quality assurance and promotion in higher education.

News Archive

DNA sequencer launched at the UFS
2013-11-25

Dr Gansen Pillay, Deputy Chief Executive Officer of the National Research Foundation, explaining to the scholars what will be expected of them.

The University of the Free State (UFS) can now collect immensely valuable data on drug resistance in HIV/Aids and TB with the new DNA sequencer that was launched recently at the International workshop on HIV/AIDS and TB drug resistance at the Bloemfontein Campus.

The DNA sequencer will allow the Free State province to produce viral and bacterial genetic data to fight the local development of HIV/ Aids and TB drug resistance.

The HIV and TB epidemics have expanded very fast and South Africa now has the largest HIV and TB treatment programme in the world, with over 2 million patients on treatment. However, these successful treatment programmes are now being threatened by the appearance of drug resistance.

The Free State province has been at the forefront of fighting HIV drug resistance in South Africa and has one of the most advanced treatment programmes for the management of resistance strains in the country. In addition, researchers at the University of the Free State are leading partners in the Southern African Treatment and Resistance Network (SATuRN; www.bioafrica.net/saturn), a research network that has trained over 2 000 medical officers in the treatment of drug resistance strains.

The Department of Medical Microbiology and Virology in the Medical School at the UFS has partnered with the provincial department of health, the Medical Research Council (MRC) and the Delegation of the European Union to South Africa to fund a dedicated DNA sequencer machine that will be used to generate HIV and TB drug-resistance results. This new machine will enable cutting-edge research to take place, using the data in the province and, importantly, support patients with resistance strains to have access to advanced genotypic testing techniques.

“HIV drug resistance is a very serious problem in South Africa, and the recent advances in DNA testing technology allow clinicians in the province to access drug resistance testing, which enables them to manage patients appropriately who fail treatment, and use the results to cost-effectively extend and improve patients’ lives,” says Dr Cloete van Vuuren, Specialist in Infectious Diseases at the UFS’s Faculty of Health.

Dr Dominique Goedhals, pathologist from the Department of Medical Microbiology and Virology at the UFS, adds: “We have been looking forward to expanding our work with the clinicians and researchers, using DNA sequencing to shed light on the causes and consequences of drug resistance in urban and rural settings in the province.”

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept